High Tech Pharm amends semiannual report to add treasury share holdings disclosure

• High Tech Pharm filed a corrected 2026 H1 report dated Sept. 29, adding previously omitted disclosures on treasury shares.
• Treasury stock holding disclosed as 575 common shares, equal to 0.0054% of shares outstanding as of June 30.
• Shares were acquired in 2024 from fractional shares generated by a Jan. 1, 2024 bonus issue.
• No board-approved long-term plan for cancellation or disposal was in place at the filing date.
• No additional buyback, cancellation, or disposal plan was disclosed as of the filing date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. High Tech Pharm Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260929000530), on September 29, 2026, and is solely responsible for the information contained therein.